Pallas Capital Advisors LLC Eli Lilly & CO Transaction History

Pallas Capital Advisors LLC

$2.37 Billion
Q3 2024

A detailed history of Pallas Capital Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 16,686 shares of LLY stock, worth $12.8 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

16,686

Previous 15,367 8.58%

Holding current value

$12.8 Million

Previous $13.9 Million 6.25%

% of portfolio

0.62%

Previous 0.6%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$772.14 - $960.02 $1.02 Million - $1.27 Million	1,319 Added 8.58%	16,686 $14.8 Million
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $407,376 - $510,880	562 Added 3.8%	15,367 $13.9 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $2.75 Million - $3.67 Million	-4,636 Reduced 23.85%	14,805 $11.5 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $237,911 - $280,465	453 Added 2.39%	19,441 $11.3 Million
Q3 2023 Nov 01, 2023	BUY	$434.7 - $599.3 $735,512 - $1.01 Million	1,692 Added 9.78%	18,988 $10.2 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $4.95 Million - $6.61 Million	14,101 Added 441.35%	17,296 $8.11 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $208,432 - $244,794	671 Added 26.58%	3,195 $1.1 Million
Q4 2022 Jan 24, 2023	SELL	$321.55 - $374.67 $123,153 - $143,498	-383 Reduced 13.18%	2,524 $0
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $69,969 - $79,737	-236 Reduced 7.51%	2,907 $1.05 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $3.22 Million - $3.78 Million	-11,538 Reduced 78.59%	3,143 $1.03 Million
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $3.02 Million - $3.76 Million	-12,876 Reduced 46.72%	14,681 $4.43 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $452,398 - $561,428	2,012 Added 7.88%	27,557 $6.7 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $904,349 - $1.11 Million	4,081 Added 19.01%	25,545 $6.8 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $555,913 - $719,069	3,079 Added 16.75%	21,464 $5.63 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $3.02 Million - $3.91 Million	18,385 New	18,385 $3.58 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.

Account

Pallas Capital Advisors LLC Eli Lilly & CO Transaction History